Latvia vs Nepal: Previously treated cases tested for RR-/MDR-TB
Latvia
80.0%
in 2022
Nepal
81.0%
in 2024
Latvia rank
114th
Nepal rank
111th
Previously treated cases tested for RR-/MDR-TB over time
- Latvia
- Nepal
How they compare
Nepal currently reports 81.0% against 80.0% in Latvia, a difference of 1.0%.
The two have swapped places 2 times across 13 shared years of data; in 2007 it was Latvia ahead.
Latvia ranks 114th and Nepal ranks 111th of 180 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.3% | 11.4% | 82.0% | Latvia |
| 2010s | 88.1% | 28.5% | 59.6% | Latvia |
| 2020s | 86.0% | 71.0% | 15.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Latvia or Nepal?
- Nepal, at 81.0% against 80.0% in Latvia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Latvia and Nepal?
- 1.0%, with Nepal ahead.
- How many years of comparable data are there for Latvia and Nepal?
- 13 years are reported by both, from 2007 to 2022.
- How do Latvia and Nepal rank globally for previously treated cases tested for rr-/mdr-tb?
- Latvia ranks 114th and Nepal ranks 111th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.